Nuclear Medicine AtlasInteractive atlas

Stress Testing for MPI

Exercise and pharmacologic stress agents, mechanisms, dosing, and contraindications

Evidence AB#cardiology#stress#MPIUpdated 2026-07-27 · Physician-reviewed
High-yield mode — key points, high-yield facts, tables & quizzes only. Toggle off for full text.

Quick Answer

Stress unmasks flow-limiting coronary disease during MPI. Exercise is preferred when the patient can adequately exercise (it adds functional/symptom data). Pharmacologic stress is used otherwise: vasodilators (regadenoson, adenosine, dipyridamole) increase coronary flow to reveal relative underperfusion in stenosed territories, while dobutamine raises myocardial demand and is reserved for patients who cannot receive vasodilators.

Exercise stress

Preferred physiologic option: provides exercise capacity, symptoms, hemodynamic and ECG response alongside perfusion. The tracer is injected at peak exercise, which the patient sustains briefly after injection. Requires the ability to reach an adequate workload.

Vasodilator stress (the workhorse for pharmacologic MPI)

Vasodilators dilate normal coronary arteries much more than stenosed ones, creating relative flow heterogeneity that appears as a perfusion defect.

Agent Mechanism Notes
Regadenoson Selective A2A adenosine-receptor agonist Fixed single-dose bolus; convenient; most common
Adenosine Nonselective adenosine agonist Continuous weight-based infusion; more side effects
Dipyridamole Blocks adenosine reuptake (raises endogenous adenosine) Longer-acting; older protocol
  • Caffeine/methylxanthines block adenosine receptors → hold ~12–24 h; caffeine is the classic cause of a false-negative vasodilator study.
  • Aminophylline reverses vasodilator effects/side effects.
  • Cautions/contraindications: high-grade AV block or sick sinus without pacemaker, and bronchospastic disease (relative — reactive airway caution).

Dobutamine stress

An inotrope/chronotrope that increases myocardial oxygen demand; used when vasodilators are contraindicated (e.g., significant bronchospasm) and exercise isn't possible. Titrated infusion ± atropine to reach target heart rate; beta-blockers reverse effects.

Preparation (all pharmacologic vasodilator studies)

  • Hold caffeine/methylxanthines ~12–24 h.
  • Screen for contraindications and reactive airway disease.
  • Continuous ECG, blood pressure, and symptom monitoring; reversal agents available.

Choosing the agent (decision logic)

  • Can the patient exercise adequately? If yes, prefer exercise — it adds workload achieved, symptoms, ECG response, and hemodynamics.
  • Reactive airway / bronchospastic disease? Vasodilators are cautioned; dobutamine is the usual alternative when exercise isn't feasible.
  • High-grade AV block / sick sinus without a pacemaker? Avoid vasodilators.
  • Recent caffeine or theophylline? Vasodilator study will be blunted — reschedule or use dobutamine.
  • Regadenoson (fixed-dose A2A-selective bolus) is the default vasodilator in many labs for its simplicity and better tolerability than adenosine.

Safety, monitoring & reversal

Continuous ECG, blood pressure, and symptom monitoring throughout, with resuscitation capability. Aminophylline reverses vasodilator effects/side effects (chest tightness, flushing, AV block); beta-blockers reverse dobutamine. Screen for contraindications and confirm an adequate caffeine washout (~12–24 h) before vasodilator stress.

What makes a stress "adequate"

Exercise studies should reach an adequate workload/heart-rate response for the perfusion result to be diagnostic; a submaximal, non-diagnostic exercise test undermines interpretation. Pharmacologic vasodilator stress does not depend on heart-rate response — hyperemia is pharmacologic — but caffeine and methylxanthines must be withheld.

Exercise first; then the right pharmacologic agent

Exercise is preferred when the patient can achieve an adequate workload — it adds exercise capacity, symptoms, ECG, and hemodynamics. Otherwise use vasodilators (regadenoson/adenosine/dipyridamole), which dilate normal vessels more than stenosed ones to reveal relative underperfusion; dobutamine (demand-based) is reserved for those who cannot receive vasodilators (e.g. significant bronchospasm). Caffeine/methylxanthines block adenosine receptors — hold ~12–24 h; they are the classic cause of a false-negative vasodilator study.

Reversal agents and the contraindication map

Match reversal to agent: aminophylline reverses vasodilator effects/side effects (chest tightness, flushing, AV block); beta-blockers reverse dobutamine. Vasodilator cautions/contraindications: high-grade AV block or sick sinus without a pacemaker and bronchospastic disease (relative). Regadenoson — a fixed-dose, A2A-selective bolus — has become the default vasodilator in many labs for simplicity and tolerability over weight-based adenosine infusion. A submaximal exercise test that never reaches an adequate workload is non-diagnostic, not "negative."

High-Yield Pearls

  • Choose exercise first when feasible — it adds prognostic functional data.
  • Regadenoson's fixed-dose simplicity has made it the default vasodilator in many labs.
  • Uninterpretable-for-ischemia study? Caffeine is the first thing to ask about.

Common Pitfalls

  • Failing to hold caffeine → blunted hyperemia and false negatives.
  • Using a vasodilator in significant reactive airway disease without considering dobutamine.
  • Inadequate exercise workload producing a non-diagnostic "stress."

Self-Check

Q1. When is exercise stress preferred, and why?

Answer: When the patient can reach an adequate workload — it adds exercise capacity, symptoms, ECG response, and hemodynamics beyond perfusion.

Q2. How do vasodilators reveal coronary stenosis, and which agent is the common default?

Answer: They dilate normal vessels more than stenosed ones, creating relative underperfusion; regadenoson (fixed-dose A2A-selective bolus) is the common default.

Q3. A vasodilator study is falsely negative for ischemia. What is the first thing to ask about?

Answer: Recent caffeine/methylxanthines — they block adenosine receptors and blunt hyperemia (hold ~12–24 h).

Q4. Match the reversal agent: vasodilator side effects vs dobutamine effects.

Answer: Aminophylline reverses vasodilator effects (chest tightness, flushing, AV block); beta-blockers reverse dobutamine.

Key References

  • ASNC/SNMMI guidelines on stress protocols for myocardial perfusion imaging.
  • Prescribing information for regadenoson, adenosine, dipyridamole, and dobutamine.

Evidence & sources

ARegadenoson non-inferiority — Iskandrian AE, et al. ADVANCE-MPI, J Nucl Cardiol 2007.
BASNC/SNMMI stress protocol guidelines — exercise vs. vasodilator vs. dobutamine.
BPrescribing information for regadenoson, adenosine, dipyridamole, dobutamine.
Cite this page. Nuclear Medicine Atlas. “Stress Testing for MPI.” v1.76, 2026-10-25. Permalink: https://nuc.med/stress-testing/ Report an issue
Nuclear Medicine Atlas · v1.76 · built 2026-10-25Terms · Privacy · Disclaimer